{"type":"video","version":"1.0","html":"<iframe width=\"560\" height=\"315\" sandbox=\"allow-same-origin allow-scripts allow-popups allow-forms\" title=\"NYC_B1O: Development of Targeted wild-type Alpha-synuclein Derivatives for Treat... (2021) - Team Presentation [English]\" src=\"https://video.igem.org/videos/embed/6bDTG4QhdF6kQdwGgrwWCK\" style=\"border: none\" allow=\"fullscreen\"></iframe>","width":560,"height":315,"title":"NYC_B1O: Development of Targeted wild-type Alpha-synuclein Derivatives for Treat... (2021) - Team Presentation [English]","author_name":"2021 Team Presentations","author_url":"https://video.igem.org/video-channels/2021_presentations","provider_name":"PeerTube","provider_url":"https://video.igem.org","thumbnail_url":"https://video.igem.org/lazy-static/thumbnails/b987612a-ad63-4df8-a011-d083a2ba45a0.jpg","thumbnail_width":850,"thumbnail_height":480}